Clinical Trials Directory

Trials / Completed

CompletedNCT04702451

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
377 (actual)
Sponsor
Volta Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a tailored ablation strategy targeting areas of spatio-temporal dispersion in combination with PVI is superior to an anatomical ablation strategy targeting PVI alone for the treatment of persistent AF.

Conditions

Interventions

TypeNameDescription
PROCEDUREDispersion ablation + PVIAblation of spatio-temporal dispersion electrograms in combination with pulmonary vein antrum isolation
DEVICEVX1VX1-based dispersion mapping
PROCEDUREPVIPulmonary vein antrum isolation

Timeline

Start date
2021-02-12
Primary completion
2023-12-27
Completion
2023-12-27
First posted
2021-01-08
Last updated
2025-09-12
Results posted
2025-09-12

Locations

26 sites across 5 countries: United States, Belgium, France, Germany, Netherlands

Regulatory

Source: ClinicalTrials.gov record NCT04702451. Inclusion in this directory is not an endorsement.